Invesco's QQQ: A Tech-Heavy Investment Focus
Explore how Invesco's reliance on QQQ exposes its portfolio to tech-heavy investments. Discover insights on portfolio diversification and tech sector dependence.
Topic
Portfolio
A collection of 5 issues
Arrow Boosts Returns with Portfolio Restructuring
Arrow Investment reshapes its portfolio, selling $75M in low-yield securities and reinvesting in higher 4.4% yield options.
Portfolio Strategy: 70% Allocation in Domestic Stocks Steady
Explore the unchanged 70% domestic stock allocation in the recommended portfolio strategy as of December 2023, emphasizing stability in investment choices.
Lake Street Sets Buy on Treace Medical, Targets $14.50
Lake Street Capital initiates Treace Medical with a Buy rating and a $14.50 price target, anticipating portfolio expansions. Learn more about this investment opportunity.
Goodman Expands Data Centre Development to 42% of Portfolio
Goodman dedicates 42% of its A$12.8 billion portfolio under development to data centres, up from 37% last year, driven by demand from Amazon, Microsoft, and Meta.